NCT05751525View on ClinicalTrials.gov

Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome

RecruitingOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

August 1, 2025

Study Completion Date

December 31, 2025

Conditions
Neurodevelopmental DisordersIntellectual DisabilityDevelopment DelayADHDAutism Spectrum DisorderEpilepsy
Interventions
DRUG

Sulfonylurea

Glibenlclamide / glyburide

Trial Locations (4)

60637

RECRUITING

University of Chicago, Chicago

Unknown

RECRUITING

University of Rome, Rome

RECRUITING

University of Bergen, Bergen

RECRUITING

University of Exeter, Exeter

All Listed Sponsors
collaborator

University of Chicago

OTHER

collaborator

University of Bergen

OTHER

collaborator

University of Rome Tor Vergata

OTHER

lead

Royal Devon and Exeter NHS Foundation Trust

OTHER